Neurology February 2023 PMID 36270895

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.

Vera Bril, Andrzej Szczudlik, Antanas Vaitkus, Csilla Rozsa, Anna Kostera-Pruszczyk, Petr Hon, Josef Bednarik, Michaela Tyblova, Wolfgang Köhler, Toomas Toomsoo, Richard J Nowak, Tahseen Mozaffar, Miriam L Freimer, Michael W Nicolle, Tim Magnus

Mentions

47
Peak: 5 in Sep 2025
across 6 sources since Oct 2022

Extended reach

14,226
potential audience

Total likes

586

Video views

4,422

Mentions per month

Oct 2022 – Oct 2025

Where it's discussed

  • Bluesky25 posts
  • X / Twitter13 posts
  • Facebook3 posts
  • YouTube2 videos
  • News2 articles
  • Blogs2 articles

AI synopsis

What people are saying

The overall tone indicates a balanced recognition of the trial’s findings, with comments like 'supports previous evidence' and mentioning the importance of rigorous methodology. The language used is straightforward, reflecting an academic or clinical tone, and the discussion revolves around the implications for treatment of myasthenia gravis, signaling a moderate yet meaningful impact in the medical community.

AgreementModerate agreement

Most discussions acknowledge the study's findings that immunoglobulin did not significantly reduce corticosteroid use, reflecting a generally aligned view on its limited efficacy.

InterestNeutral interest

Some discussions show neutral or minimal curiosity, with a few posts simply referencing the study without deep analysis or emotional tone.

EngagementModerate engagement

Several posts engage with the research by mentioning the methodology or implications, such as emphasizing the trial's design or discussing its clinical significance.

ImpactModerate impact

The discussions suggest moderate impact, recognizing that the study contributes valuable data to treatment debates, though it does not seem to dramatically shift current perceptions.

Abstract in brief

  • This study tested whether immunoglobulin (IGIVC) could help people with myasthenia gravis (MG) reduce their corticosteroid (CS) doses.
  • The results showed that IGIVC did not significantly decrease CS doses more than a placebo, and both treatments were generally well tolerated.
  • Overall, IGIVC was not more effective than placebo in reducing corticosteroid use in MG patients, indicating that their mechanisms might differ.]

Top posts

Most liked on X and Bluesky
Eric Topol
@erictopol.bsky.social · Bluesky

A randomized, double-blind. placebo-controlled trial of modulating the gut microbiome is successful for symptom alleviation in Long Covid www.thelancet.com/journals/lan...

Dec 7, 2023 · 497 likes · 199 shares View post →
Denis - The COVID Info Guy
@thecovidinfoguy.bsky.social · Bluesky

Study: A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19 Published: 01 August 2025 www.nature.com/articles/s41...

Aug 4, 2025 · 41 likes · 9 shares View post →
Nature Communications
@natcomms.nature.com · Bluesky

A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate #COVID19 #DrugDiscovery #SarsCoV2 #COVID

Oct 5, 2025 · 5 likes · 1 share View post →
Transfusion Evidence Library
@transfusionlib.bsky.social · Bluesky

New from #Transfusion Evidence Library: Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding by Prasad et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

Sep 10, 2025 · 2 likes · 1 share View post →
Transfusion Library
@TransfusionLib · X

From our #Transfusion Evidence Alert this month: A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in #MyastheniaGravis by Bril et al. https://t.co/DtOax3zNCF https://t.co/kZTAIKq1hq

Dec 6, 2022 · 1 like · 2 shares · 3,317 followers View post →
mntryjoseph61.bsky.social
@mntryjoseph61.bsky.social · Bluesky

What were the results of a randomized, double-blind, placebo-controlled trial of a daily half teaspoon of powdered black cumin in Hashimoto’s patients?

Jun 26, 2025 · 1 like View post →

All mentions

Nature Communications
@natcomms.nature.com · Bluesky

A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate #COVID19 #DrugDiscovery #SarsCoV2 #COVID

Oct 10, 2025 · 1 like View post →
Nature Communications
@natcomms.nature.com · Bluesky

A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate #COVID19 #DrugDiscovery #SarsCoV2 #COVID

Oct 5, 2025 · 5 likes · 1 share View post →
mntryjoseph61.bsky.social
@mntryjoseph61.bsky.social · Bluesky

Lactucin, the hypnotic component of lettuce, is put to the test in a randomized, double-blind, placebo-controlled trial of lettuce seeds.

Sep 26, 2025 · 1 like View post →
NotQuietMode_M.D.
@notquietmodemd.bsky.social · Bluesky

I patiently await the randomized double blind placebo-controlled trial of bottle of Jagermeister for breakfast, 8 ball of meth for lunch, and a vegan shake for dinner w/ no artificial dyes versus placebo WTF

Sep 19, 2025 · 1 like View post →
Transfusion Evidence Library
@transfusionlib.bsky.social · Bluesky

New from #Transfusion Evidence Library: Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding by Prasad et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

Sep 10, 2025 · 2 likes · 1 share View post →
#NeuroDegeneration preprints
@prepub-neurodegen.bsky.social · Bluesky

A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial of Intracisternal Engineered Autologous Exosomes (NV-101) to Restore Neuronal Proteostasis in Early Alzheimer's Disease: The RESTORE Protocol #NeuroDegeneration

Sep 10, 2025 View post →
medRxivpreprint
@medrxivpreprint.bsky.social · Bluesky

A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial of Intracisternal Engineered Autologous Exosomes (NV-101) to Restore Neuronal Proteostasis in Early Alzheimer's Disease: The RESTORE Protocol https://www.medrxiv.org/content/10.1101/2025.09.04.25335118v1

Sep 9, 2025 View post →
brandon-beaber.bsky.social
@brandon-beaber.bsky.social · Bluesky

Do omega 3 supplements actually do anything for people with MS? This Randomized, Double-Blind, Placebo-Controlled Trial of DHA + EPA found no statistically significant difference in relapses, MRI lesions, disability progression, quality of life, or fatigue jamanetwork.com/journals/jam...

Aug 5, 2025 · 1 like · 1 share View post →
Denis - The COVID Info Guy
@thecovidinfoguy.bsky.social · Bluesky

Study: A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19 Published: 01 August 2025 www.nature.com/articles/s41...

Aug 4, 2025 · 41 likes · 9 shares View post →
GMIK69BSKY
@gmik69bsky.bsky.social · Bluesky

A randomized, double-blind, placebo-controlled trial of #niclosamide nanohybrid for #treatment of patients with mild to moderate #COVID19, etidiohnew.blogspot.com/2025/08/a-ra...

Aug 4, 2025 View post →
Climate, Ecology, War & More by Dr. Glen Barry, BigEarthData.ai
@bigearthdata.bsky.social · Bluesky

A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19 ->Nature | #Covid19 | More info from EcoSearch

Aug 1, 2025 View post →
mntryjoseph61.bsky.social
@mntryjoseph61.bsky.social · Bluesky

What were the results of a randomized, double-blind, placebo-controlled trial of a daily half teaspoon of powdered black cumin in Hashimoto’s patients?

Jun 26, 2025 · 1 like View post →
Iván Darío Bravo Tobar. M.D. | M.Sc. | Ph.D.
@idbravotobar.bsky.social · Bluesky

A randomized, double‐blind, placebo‐controlled trial of abatacept for the treatment of relapsing, non‐severe, granulomatosis with polyangiitis - Langford - Arthritis & Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/...

Jun 22, 2025 View post →
@vasculitides
@vasculitides.bsky.social · Bluesky

A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitis

Jun 16, 2025 View post →
St Vincent's Healthcare Group Libraries
@svhglibraries.bsky.social · Bluesky

A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granu… pubmed.ncbi.nlm.nih.gov/40506793/

Jun 16, 2025 · 1 share View post →
mary
@roughrider994.bsky.social · Bluesky

A Randomized, Double-blind, Placebo-Controlled Trial of Terminalia Chebula and Terminalia Bellerica For Hyperuricemia www.thefocalpoints.com/p/a-randomiz...

May 12, 2025 View post →
Clinical Gastroenterology and Hepatology
@aga-cgh.bsky.social · Bluesky

Apr 11, 2025 View post →
Waggoner Lab
@labwaggoner.bsky.social · Bluesky

A randomized, double-blind, placebo controlled trial of IL-7 in critically ill COVID-19 patients revealed reduced nosocomial infections insight.jci.org/articles/vie... @jci-insight.bsky.social

Feb 4, 2025 View post →
UCL Discovery
@ucldiscovery.bsky.social · Bluesky

Open Access UCL Research: IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab discovery.ucl.ac.uk/id/eprint/10...

Feb 4, 2025 View post →
Dr. Karl Nadolsky
@drkarlnadolsky.bsky.social · Bluesky

Nov 25, 2024 View post →
Cristina Popa
@nephroseeker.medsky.social · Bluesky

2/ DEFEaT -AKI WAS Phase Il, randomized, double blind, placebo-controlled trial of IV deferoxamine in patients undergoing CABG or valve surgery with CPB #kidneywk

Oct 25, 2024 · 1 share View post →
Cristina Popa
@nephroseeker.medsky.social · Bluesky

3/ FINEARTS-HF Study Design Randomized, double-blind, placebo-controlled trial of patients with HFmrEF/HFpEF Inclusion and exclusion criteria #KidneyWk

Oct 25, 2024 View post →
ES/IODE
@esiode.bsky.social · Bluesky

Sep 8, 2024 View post →
ES/IODE
@esiode.bsky.social · Bluesky

Sep 5, 2024 View post →
Eric Topol
@erictopol.bsky.social · Bluesky

A randomized, double-blind. placebo-controlled trial of modulating the gut microbiome is successful for symptom alleviation in Long Covid www.thelancet.com/journals/lan...

Dec 7, 2023 · 497 likes · 199 shares View post →
Myasthénie - AMIS
@Myasthenie_AMIS · X

RT @Myasthenie_AMIS: Echos de la recherche • [Pubmed] Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effect…

May 16, 2023 · 1 share · 484 followers View post →
Myasthénie - AMIS
@Myasthenie_AMIS · X

Echos de la recherche • [Pubmed] Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Mya https://t.co/Wo1zKEdXaT

May 15, 2023 · 1 share · 484 followers View post →
Raising Square Pegs
@RaisingSqrPegs · X

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis | Neurology https://t.co/O6mWtqUf7U

Mar 13, 2023 · 651 followers View post →
Raising Square Pegs
@RaisingSqrPegs · X

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis | Neurology https://t.co/O6mWtqUf7U

Mar 7, 2023 · 651 followers View post →
BrainSights iOS App
@BrainSightsApp · X

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis - AAN Neurology via BrainSights for iOS https://t.co/rR5Z27ZLe8

Feb 13, 2023 · 312 followers View post →
Dataemia
@Dataemia · X

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis - https://t.co/jE2iEpwGny

Feb 13, 2023 · 967 followers View post →
Shiva Gopal Vasishta
@ShivaVasishta · X

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis https://t.co/kJyIAmkzJk #neurology #doctors #medtwitter #medical #medicinenews #healthcare

Feb 13, 2023 · 336 followers View post →
SRI - Systematic Review Initiative
@sritransfusion · X

RT @TransfusionLib: From our #Transfusion Evidence Alert this month: A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticost…

Dec 6, 2022 · 2 shares · 668 followers View post →
Transfusion Library
@TransfusionLib · X

From our #Transfusion Evidence Alert this month: A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in #MyastheniaGravis by Bril et al. https://t.co/DtOax3zNCF https://t.co/kZTAIKq1hq

Dec 6, 2022 · 1 like · 2 shares · 3,317 followers View post →
Sheetal Shroff
@ShroffNMD · X

A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis https://t.co/V7QM4z4TfB

Nov 6, 2022 · 69 followers View post →
Myasthénie - AMIS
@Myasthenie_AMIS · X

RT @Myasthenie_AMIS: Echos de la recherche • [Pubmed] A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Ef…

Oct 23, 2022 · 1 share · 484 followers View post →
Myasthénie - AMIS
@Myasthenie_AMIS · X

Echos de la recherche • [Pubmed] A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in https://t.co/If2pdB6Y7x

Oct 22, 2022 · 1 share · 484 followers View post →
Paperbirds_Neurology
@PaperbirdsN · X

New article: A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis https://t.co/gFrpbnTYd7 #MG #myastheniagravis #neurology https://t.co/b2yrGswFZK

Oct 22, 2022 · 456 followers View post →